On 5th January 2011, we Trainee of BesT programme UniRazak , have Students visit to Inno Biologics at Putra Nilai, Negeri Sembilan . Our jouney takes about 1 hour, by bus. The other group was visit Stellagen that located at Sri Batu Caves Industrial Park .
Inno Biologics was well established in 2002, and Inno Biologics is Malaysia’s first cGMP modular biopharmaceutical production plant. Inno Biologics specializes in mammalian cell culture technology and operates the state-of-the-art cGMP facility for the production of biopharmaceuticals. The facility is built to comply with European Medical Agency (EMEA) and United States Food and Drug Administration (FDA) regulatory requirements. Inno Biologics has entered into a 10-year cooperation agreement with Boehringer Ingelheim to have non-exclusive access to Boehringer Ingelheim’s comprehensive manufacturing technology platform for biopharmaceutical production. Inno Biologics also have strategic collaboration with the commercial arm of Centre of Molecular Immunology (CIM), Cuba in Technology licensing for the Humanisation of Antibody. With the GE Healthcare, a conferment on seed site status to Inno Biologics. Inno Biologics will gain preferred access to GE latest innovation of related technology.
They offer complete services from upstream to downstream operation for the development of customer’s therapeutic proteins. Their reliable, rapid and cost effective services will reduce risks, cost and time investment. This will ensure their customers will get the product candidates into the market in line with their vision and strategy. This is the list for complete range of services provided by Inno Biologics ; contract research, antibody development, humanization services, cell line development, protein expression, yield improvement, cell banking, process development, analytics, scale up from non cGMP to cGMP and cGMP manufacturing – 200L & 1000L.
From this visit, all of we were brought by Inno Bio executive team to visit around Inno Biologics. The coverage area of Inno Biologics quite large and wide. Inno Biologics , they were provide the services to the clients like I said in previous paragraph. There’s a large scale of laboratory ; Process Science Laboratory and Protein Science Laboratory. In Process Science Laboratory was involved with Purification Laboratory, Filtration Laboratory and Bioreactor and Recovery Laboratory. There’s a big reactor that used for operation process. In Inno Biologics have the manufacturing sector that operates the state-of-the-art cGMP facility for the production of biopharmaceuticals. For Stellagen, is a Biotech Company with the primary objective to identify, develop and commercialise technologies related to animal health, consumer health, microbiology and biochemical industries. StellarLac(TM), which has undergone a 12 years research in UPM. This product is a feed supplement for poultry and it is meant to replace the antibiotics as growth promoter. It is known as probiotic since the product is consisted of 11 strains of friendly bacteria that can improve a chicken's intestinal bacteria balance and its digestion of chicken feed. It also helps to restore the presence of beneficial bacteria, which strengthen the intestinal system against disease-causing organisms. This makes Stellarlac the most suitable alternative for antibiotics as growth promoter since the usage of the latter will be banned internationally starting from 1 January 2006. This company is a growing company, there 2% market they have penetrated and mostly in Southern Malaysia. This company was small in place and also just have five team members, that located at Sri Batu Caves Industrial Park
My opinion about Inno Biologics in future about 10 years, is I hope Inno Biologics will fulfill the the mission and vison that they holds. Inno Biologics must to expand effort to ensure the sustainabilitygrowth. . Inno Biologics will be a world leading business organisation providing biopharmaceutical development and services for better quality of life. And Inno Biologics now already on the right track in order to be the leader in innovative biologics development and manufacturing. By achieving that Inno Biologics will give full contribution to the nation’s economic growth. By the increasing development in the future, they will create critical mass of talent in biorelated industries.
As conclusion, this visit was a great and so much useful for me and all of us. From this visit, it’s open my eyes clearly to the future career and what particular environment for my future jobs. And I hope one day I willl work with Inno Biologics. Thank you to S.E.E.D and Biotechcorp for giving us this great opportunity.
No comments:
Post a Comment